We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRA icon
251
Biomerica
BMRA
$5.01M
$95K ﹤0.01%
2,375
+1,125
+90% +$56.4K
CRS icon
252
Carpenter Technology
CRS
$28.8B
$84K ﹤0.01%
2,870
– –
LEAF
253
DELISTED
Leaf Group Ltd.
LEAF
$84K ﹤0.01%
+18,000
New +$99.2K
SEM
254
DELISTED
Select Medical
SEM
$78K ﹤0.01%
5,252
– –
CRM icon
255
Salesforce
CRM
$142B
$75K ﹤0.01%
335
– –
LESL icon
256
Leslie's
LESL
$10.8M
$73K ﹤0.01%
+132
New +$59.4K
TIG
257
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$69K ﹤0.01%
5,250
-3,058
-37% -$40.7K
MLVF
258
DELISTED
Malvern Bancorp, Inc.
MLVF
$66K ﹤0.01%
4,263
– –
VG
259
DELISTED
Vonage Holdings Corporation
VG
$62K ﹤0.01%
4,780
-4,028
-46% -$49K
TBCH
260
Turtle Beach Corp
TBCH
$245M
$60K ﹤0.01%
2,800
+1,667
+147% +$33.2K
ABT icon
261
Abbott
ABT
$182B
$59K ﹤0.01%
535
– –
DMTK
262
DELISTED
DermTech, Inc. Common Stock
DMTK
$50K ﹤0.01%
+1,550
New +$22K
PFIS icon
263
Peoples Financial Services
PFIS
$703M
$42K ﹤0.01%
1,151
– –
CNNE icon
264
Cannae Holdings
CNNE
$650M
$40K ﹤0.01%
900
-534
-37% -$21.7K
AMT icon
265
American Tower
AMT
$77.7B
$39K ﹤0.01%
175
– –
CVS icon
266
CVS Health
CVS
$137B
$39K ﹤0.01%
576
+5
+0.9% +$325
CSCO icon
267
Cisco
CSCO
$452B
$37K ﹤0.01%
827
+8
+1% +$329
APD icon
268
Air Products & Chemicals
APD
$65.2B
$30K ﹤0.01%
110
– –
BURL icon
269
Burlington
BURL
$22.5B
$30K ﹤0.01%
115
– –
GS icon
270
Goldman Sachs
GS
$309B
$29K ﹤0.01%
110
– –
ORGO icon
271
Organogenesis Holdings
ORGO
$328M
$26K ﹤0.01%
+3,500
New +$16.6K
ODFL icon
272
Old Dominion Freight Line
ODFL
$47.2B
$25K ﹤0.01%
260
– –
ATEX icon
273
Anterix
ATEX
$1.83B
$23K ﹤0.01%
600
-500
-45% -$16.5K
TGT icon
274
Target
TGT
$63.7B
$23K ﹤0.01%
130
– –
ONEM
275
DELISTED
1Life Healthcare
ONEM
$21K ﹤0.01%
490
– –
9 10
11
12 13

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.